Fecal Occult Testing Market Overview
As per MRFR analysis, the Fecal Occult Testing Market Size was estimated at 3.34 (USD Billion) in 2022. The Fecal Occult Testing Market is expected to grow from 3.59 (USD Billion) in 2023 to 6.8 (USD Billion) by 2032. The Fecal Occult Testing Market CAGR (growth rate) is expected to be around 7.36% during the forecast period (2024 - 2032).
Key Fecal Occult Testing Market Trends Highlighted
Growing rates of colorectal cancer and gastrointestinal disorders, coupled with growing awareness of early cancer detection, are driving the global market for fecal occult testing. Developments in technology, such the creation of tests that are more precise and sensitive, are also driving market expansion.
Opportunities exist to increase the use of fecal occult testing, especially in poor countries, for population-based screening initiatives. Other prospects include the incorporation of fecal occult testing into standard medical examinations and the creation of non-invasive, approachable diagnostic techniques.
The use of quantitative fecal immunochemical assays (FIT), which yield more precise results and improved detection rates, is one of the most recent advancements. Significant progress has been made with the creation of molecular-based fecal occult tests that can identify particular genetic markers linked to colorectal cancer.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Fecal Occult Testing Market Drivers
Rising Incidence of Colorectal Cancer
Colorectal cancer is the third leading cause of cancer-related deaths worldwide, with an estimated 1.9 million new cases and 935,000 deaths in 2020. The incidence of colorectal cancer has been increasing in recent years, particularly in developing countries.
This is due to a number of factors, including changes in diet and lifestyle, as well as the aging population. The rising incidence of colorectal cancer is expected to drive demand for fecal occult testing (FOT) as a screening tool.
FOT is a simple, non-invasive test that can detect hidden blood in the stool, which may be a sign of colorectal cancer or other gastrointestinal disorders.
The increasing awareness of colorectal cancer and the benefit of early detection is expected to further fuel the growth of the Fecal Occult Testing Market.
Government Initiatives and Screening Programs
As Governments from different parts of the globe started understanding the benefits of colorectal cancer screening, they started implementing the programs that would make access to FOT easier.
For instance, in the United States, the Centers for Disease Control and Prevention recommend regular colorectal cancer for adults aged 50 years and above.
Medicare, which is the national health insurance program for senior citizens in the United States, started covering the cost of FOT for the beneficiaries who are interested in the service, but only when they meet the criteria set.
Similar programs also came to light in many other countries. Expansion of government initiatives and promotion related to colorectal cancer and FOT screening is a factor that is expected to drive the growth of the Fecal Occult Testing Market by increasing the number of people with access to FOT.
Technological Advancements
Technological advancements are also contributing to the growth of the Fecal Occult Testing Market. New technologies are making FOT more accurate, sensitive, and user-friendly.
For example, some new FOT tests use antibodies to detect specific biomarkers in the stool, which can improve the accuracy of the test. Other new FOT tests are designed to be more user-friendly, with features such as built-in sample collection devices and easy-to-read results.
Technological advancements are expected to continue to drive the growth of the Fecal Occult Testing Market by making FOT more accessible and appealing to patients.
Fecal Occult Testing Market Segment Insights
Fecal Occult Testing Market Product Type Insights
The Fecal Occult Testing Market is segmented by product type into Immunochemical Fecal Occult Blood Tests (iFOBT) and Guaiac-Based Fecal Occult Blood Tests (gFOBT). The iFOBT segment held a dominant market share in 2023 and is expected to continue its dominance throughout the forecast period.
The growth of this segment can be attributed to the increasing adoption of iFOBTs due to their high sensitivity and specificity in detecting fecal occult blood. iFOBTs use antibodies to detect the presence of human hemoglobin in stool samples, which is indicative of bleeding in the gastrointestinal tract.
The high sensitivity of iFOBTs allows for the early detection of colorectal cancer (CRC), which is the third leading cause of cancer death worldwide. The Guaiac-Based Fecal Occult Blood Tests (gFOBT) segment is expected to witness a steady growth rate during the forecast period.
gFOBTs are less sensitive and specific than iFOBTs, but they are less expensive and easier to perform. The Fecal Occult Testing Market is expected to reach a market value of USD 3.9 billion by 2028, expanding at a CAGR of 7.8% from 2024 to 2032.
The rising incidence of colorectal cancer, increasing awareness about the importance of early detection, and the growing adoption of advanced fecal occult testing technologies are driving the growth of the Fecal Occult Testing Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Fecal Occult Testing Market Specimen Type Insights
The Fecal Occult Testing Market is segmented by specimen type. Based on the specimen type, from the fecal samples and stool samples. The fecal samples accounted for the largest share of the market in 2023, and it will continue during the forecast period.
Fecal samples accounted for the largest share of the market as it is the most common sample collected for fecal occult testing. Stool samples are also used for the testing, but they are not as commonly collected as fecal samples.
The increasing occurrence of colorectal cancer and the increasing awareness of early diagnosis is the key growth reason for this market.
Fecal Occult Testing Market End Users Insights
The end users of fecal occult testing kits include hospitals, clinics, diagnostic laboratories, and research institutions.
Hospitals accounted for the largest share of the Fecal Occult Testing Market revenue in 2023, owing to the increasing number of patients suffering from colorectal cancer and the rising demand for early detection and screening.
Clinics are also expected to contribute significantly to the market growth due to their role in providing primary healthcare services and offering fecal occult testing as part of routine health checkups.
Diagnostic laboratories play a crucial role in analyzing fecal samples and providing accurate results, driving the market demand.
Research institutions are actively involved in developing advanced fecal occult testing technologies and conducting studies to improve the accuracy and efficacy of these tests.
The increasing prevalence of colorectal cancer and the growing awareness about the importance of early detection are key factors fueling the growth of the fecal occult testing market.
Fecal Occult Testing Market Application Insights
The Fecal Occult Testing Market is segmented by Application into Colorectal Cancer Screening, Gastrointestinal Disorders Diagnosis, Inflammatory Bowel Disease Detection and others.
Colorectal Cancer Screening is the largest application segment, accounting for over 50% of the Fecal Occult Testing Market revenue in 2023.
The high prevalence of colorectal cancer and the increasing awareness of the benefits of early detection are driving the growth of this segment. Gastrointestinal Disorders Diagnosis is the second largest application segment, with a market share of over 25%.
The rising incidence of gastrointestinal disorders such as irritable bowel syndrome and Crohn's disease is fueling the demand for fecal occult testing in this segment. Inflammatory Bowel Disease Detection is the third largest application segment, with a market share of over 20%.
The increasing prevalence of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease is driving the growth of this segment. The Fecal Occult Testing Market is expected to witness significant growth over the forecast period, with a CAGR of over 7% during 2024-2032.
Fecal Occult Testing Market Detection Technology Insights
The Fecal Occult Testing Market is segmented by Detection Technology into ELISA, Immunochromatography, and Spectrophotometry. Among these, the ELISA segment held the largest market share in 2023, accounting for over 40% of the global market.
ELISA is a widely used technique due to its high sensitivity and specificity, which makes it suitable for detecting small amounts of fecal blood. The Immunochromatography segment is expected to grow at the highest CAGR during the forecast period, owing to its ease of use and rapid results.
Spectrophotometry is another commonly used technique, particularly in low-resource settings, due to its affordability and simplicity.
The Fecal Occult Testing Market revenue for the Detection Technology segment is projected to reach USD 2.4 billion by 2024, exhibiting a steady growth trajectory.
Fecal Occult Testing Market Regional Insights
North America holds the largest market share due to the high prevalence of colorectal cancer, advanced healthcare infrastructure, and government initiatives for early cancer detection.
Europe is another significant market, driven by rising awareness about colorectal cancer screening programs and technological advancements in fecal occult testing.
The APAC region is expected to witness the fastest growth rate owing to the increasing incidence of colorectal cancer, expanding healthcare expenditure, and growing awareness about early cancer screening.
South America and MEA are emerging markets with a growing demand for fecal occult testing as a cost-effective and non-invasive screening method for colorectal cancer.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Fecal Occult Testing Market Key Players and Competitive Insights
The Fecal Occult Testing Market players are increasingly investing in product development to set new benchmarks for the industry. For instance, FUJIFILM Wako Pure Chemical Corporation launched the FOB Turbo CARD in June 2021.
It is a new fecal occult blood test kit that facilitates the qualitative detection of human hemoglobin in feces.
Health workers can read the test results in 2 minutes through the specialized Turbo Reader Fecal Occult Testing Market. Hence, such efforts are propelling the advancements in the Fecal Occult Testing Market and pushing the companies ahead of their peers.
The major company in the Fecal Occult Testing Market is FUJIFILM Wako Pure Chemical Corporation. The company offers several fecal occult testing products including the FOB Turbo CARD and FOB CHECK products.
The company’s products are extensively used in clinical settings to diagnose the early stages of colorectal cancer or any other gastrointestinal diseases. Its popular brand and large distribution network help it maintain a significant market share in the Fecal Occult Testing Market.
Based on its continuous product innovation and customer-centric approach, the company left no yardstick to ensure it is the leading player in this industry.
The other player in the Fecal Occult Testing Market is Helena Laboratories. The product is synonymous with a broad range of gastroenterology diagnostic products including the HemoQuant FOB Test and HemoQuant Flex FOB Test.
They are used for determining the presence of fecal occult in the stool, a hallmark of various gastrointestinal diseases, including colorectal cancer. Its products are used across the globe by various health workers in hospitals, clinics, and diagnostic laboratories.
This company has gained high market significance in the Fecal Occult Testing Market sector due to product reliability and quality standardization efforts.
Key Companies in the Fecal Occult Testing Market Include:
- BD
- Trinity Biotech
- Meridian Bioscience
- Quidel Corporation
- Eiken Chemical
- Beckman Coulter
- Inova Diagnostics
- BioRad
- Alere Inc.
- Roche Diagnostics
- Sysmex Corporation
- US Diagnostics
- Sekisui Diagnostics
- Siemens Healthineers
- Abbott Laboratories
Fecal Occult Testing Market Developments
The rising awareness about colorectal cancer and the increasing prevalence of gastrointestinal diseases are key factors driving market growth. Technological advancements, such as the development of highly sensitive and specific fecal immunochemical tests (FITs), are further fueling market expansion.
Additionally, government initiatives and reimbursement policies aimed at promoting early detection of colorectal cancer are creating favorable market conditions. Key players in the market include QIAGEN, Sysmex Corporation, and Bio-Rad Laboratories, among others.
Recent developments include the launch of new FIT products with enhanced accuracy, and the expansion of market reach through strategic partnerships and acquisitions.
Fecal Occult Testing Market Segmentation Insights
Fecal Occult Testing Market Product Type Outlook
- Immunochemical Fecal Occult Blood Tests (iFOBT)
- Guaiac-Based Fecal Occult Blood Tests (gFOBT)
Fecal Occult Testing Market Specimen Type Outlook
- Fecal Samples
- Stool Samples
Fecal Occult Testing Market End Users Outlook
- Hospitals
- Clinics
- Diagnostic Laboratories
- Research Institutions
Fecal Occult Testing Market Application Outlook
- Colorectal Cancer Screening
- Gastrointestinal Disorders Diagnosis
- Inflammatory Bowel Disease Detection
Fecal Occult Testing Market Detection Technology Outlook
- ELISA
- Immunochromatography
- Spectrophotometry
Fecal Occult Testing Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
3.34(USD Billion) |
| Market Size 2023 |
3.59(USD Billion) |
| Market Size 2032 |
6.8(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
7.36% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
BD, Trinity Biotech, Meridian Bioscience, Quidel Corporation, Eiken Chemical, Beckman Coulter, Inova Diagnostics, BioRad, Alere Inc., Roche Diagnostics, Sysmex Corporation, US Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Abbott Laboratories |
| Segments Covered |
Product Type, Specimen Type, End Users, Application, Detection Technology, Regional |
| Key Market Opportunities |
Growing awareness of colorectal cancer Rising prevalence of gastrointestinal disorders Technological advancements in fecal occult testing Increasing healthcare expenditure in emerging markets Expanding healthcare infrastructure |
| Key Market Dynamics |
High demand for early cancer screening Technological advancements Increasing awareness of colorectal cancer Government initiatives Growing healthcare expenditure |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Fecal Occult Testing Market is expected to reach USD 6.8 Billion by 2032, growing at a CAGR of 7.36% from 2024 to 2032.
North America is expected to hold the largest market share in the Fecal Occult Testing Market throughout the forecast period.
The colorectal cancer screening segment is expected to hold the largest market share in the Fecal Occult Testing Market throughout the forecast period.
The increasing incidence of colorectal cancer, the growing demand for early detection and screening methods, and the technological advancements in fecal occult testing are the key factors driving the growth of the Fecal Occult Testing Market.
Some of the key competitors in the Fecal Occult Testing Market include Abbott Laboratories, Sysmex Corporation, FUJIFILM Holdings Corporation, Biohit Healthcare, and Beckman Coulter.
The Fecal Occult Testing Market is expected to grow at a CAGR of 7.36% from 2024 to 2032.
The base year for the Fecal Occult Testing Market is 2023.
The end year for the Fecal Occult Testing Market is 2032.
The CAGR of the Fecal Occult Testing Market is 7.36%.
The market value of the Fecal Occult Testing Market in 2023 was USD 3.59 Billion.
